Peroxisome Proliferator-Activated Receptor-γ Agonist Treatment Increases Septation and Angiogenesis and Decreases Airway Hyperresponsiveness in a Model of Experimental Neonatal Chronic Lung Disease

Chronic lung disease (CLD) affects premature newborns requiring supplemental oxygen and results in impaired lung development and subsequent airway hyperreactivity. We hypothesized that the maintenance of peroxisome proliferator-activated receptor gamma (PPARγ) signaling is important for normal lung...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Takeda, K., Okamoto, M., De Langhe, S., Dill, E., Armstrong, M., Reisdorf, N., Irwin, D., Koster, M., Wilder, J., Stenmark, K.R., West, J., Klemm, D., Gelfand, E.W., Nozik-Grayck, E., Majka, S. M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2873208/
https://ncbi.nlm.nih.gov/pubmed/19484746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ar.20921
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados